PENTAXIM

This brand name is authorized in Brazil, Croatia, Cyprus, Estonia, Hong Kong SAR China, Lithuania, Poland, Singapore, South Africa, Tunisia, Turkey.

Active ingredients

The drug PENTAXIM contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Tetanus toxoid UNII `K3W1N8YP13` - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Tetanus toxoid
`2`	Diphtheria toxoid UNII `IRH51QN26H` - CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Diphtheria toxoid
`3`	Pertussis toxoid UNII `F4TN0IPY37` - BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)
	Read more about Pertussis toxoid
`4`	Pertussis filamentous hemagglutinin UNII `8C367IY4EY` - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Pertussis filamentous hemagglutinin
`5`	Mahoney strain UNII `0LVY784C09` - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 1
`6`	MEF-1 strain UNII `23JE9KDF4R` - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 2
`7`	Saukett strain UNII `459ROM8M9M` - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 3
`8`	Polysaccharide of Haemophilus influenzae type b UNII `LUY6P8763W` - HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN
	Read more about

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PENTAXIM Powder and suspension for suspension for injection	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07CA06	Diphtheria-Haemophilus influenzae B-pertussis-poliomyelitis-tetanus	J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	502820050079907, 502820050080007, 576720060074417, 576720060074517, 576720090087107, 576720090087207
EE	Ravimiamet	1135033, 1135044, 1135055
HK	Department of Health Drug Office	56018
HR	Agencija za lijekove i medicinske proizvode	HR-H-854134391
LT	Valstybinė vaistų kontrolės tarnyba	1012679, 1068299, 1068300, 1068301, 1068512, 1068513
PL	Rejestru Produktów Leczniczych	100192717
SG	Health Sciences Authority	14795P
TN	Direction de la Pharmacie et du Médicament	12063051
TR	İlaç ve Tıbbi Cihaz Kurumu	8699625960336
ZA	Health Products Regulatory Authority	A38/30.1/0525

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.